Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Thiosulfinate" patented technology

In organosulfur chemistry, thiosulfinate is a functional group consisting of the linkage R-S(O)-S-R (R are organic substituents). Thiolsulfinates are also named as alkanethiosulfinic (or arenethiosulfinic) acid esters. They are the first member of a family of compounds containing an oxidized disulfide bond. Other members of this family include thiosulfonates (R-SO₂-S-R), α-disulfoxides (R-S(O)-S(O)-R), sulfinyl sulfones (R-S(O)-SO₂-R), and α-disulfones (R-SO₂-SO₂-R), all of which are known. The thiosulfinate group can occur in cyclic as well as acyclic structures.

Antimicrobial compositions

PendingUS20260083126A1BiocideAntibacterial agentsBiotechnologyThiosulfinate
The disclosure relates to organosulfur compounds and compositions comprising same. In particular, the disclosure relates to Bis(4-fluorophenyl) disulfide, Bis(4-chlorophenyl) disulfide, Bis(4-chlorophenyl) thiosulfinate, Bis(4-fluorophenyl) thiosulfinate, Bis(4-chlorophenyl) thiosulfonate, Bis(4-fluorophenyl) thiosulfonate, and Di-isopropyl thiosulfonate. Such compositions are useful for treating microbial infection, in particular bacterial, fungal, rotozoan or algal infection. Compositions comprising said compounds are also provided for cleaning, disinfecting or agricultural use.
Owner:AHV INT BV

Bayer Williger monooxygenase mutant and application thereof

PendingCN122071689ABacteriaMicroorganism based processesThiosulfinateOxygenase
The invention discloses a Bayer Williger monooxygenase mutant and an application of the Bayer Williger monooxygenase mutant. The invention provides a monooxygenase mutant, and compared with an amino acid sequence shown as SEQ ID NO: 1, an amino acid sequence of the monooxygenase mutant contains amino acid residue difference of one or more sites; the activity of the monooxygenase mutant is improved compared with that of Bayer-Williger monooxygenase with the amino acid sequence shown as SEQ ID NO: 1, wherein the amino acid sequence of the Bayer-Williger monooxygenase is shown as SEQ ID NO: 1. According to the monooxygenase mutant provided by the invention, the chiral thiosulfinate compound can be generated with relatively high yield and stereoselectivity, and the reaction condition is mild.
Owner:SHANGHAI SYNTHEALL PHARM CO LTD

Compounds for reducing lactation and improving health

PendingUS20260083687A1Hydrolysed protein ingredientsSulfur/selenium/tellurium active ingredientsThiosulfinateThiosulfinic acids
Preferred compounds include di-n-propyl disulfide, di-methyl disulfide, di-ethyl disulfide, di-isopropyl disulfide, di-n-butyl-disulfide, di-benzyl disulfide, di-ethyl sulfide, di-n-propyl sulfide, di-isopropyl sulfide, di-n-butyl sulfide, di-phenyl sulfide, di-benzyl sulfide, di-n-propyl trisulfide, di-n-propyl sulfone, di-benzyl thiosulfinate, di-benzyl thiosulfonate, di-isopropyl thiosulfonate, di-n-propyl thiosulfonate (PTSO), and di-n-propyl thiosulfinate (PTS).
Owner:AHV INT BV